Metabolic Syndrome: all 2,011 studies

Page 19 of 21. Open to participants first (334), then studies with results posted, then the rest; newest registration first within each.

• Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism in Males With the Metabolic SyndromeCompletedNCT00721552Not applicable
• Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome.WithdrawnNCT00720616Not applicable
• Association of Multiple Genetic Polymorphisms With Clozapine-Associated Metabolic Change in SchizophreniaStatus unknownNCT00717509
• High Density Lipoprotein (HDL) Functionality in Metabolic SyndromeStatus unknownNCT00716300
• A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.CompletedNCT00703755Phase 2
• MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016)TerminatedNCT00703690Phase 2
• The Effect of Acute and Chronic Exercise at the Metabolic Syndrome and Markers of Inflammation in Obese SubjectsStatus unknownNCT00700245Not applicable
• Odense Androgen Study - The Effect of Testim and Training in Hypogonadal MenStatus unknownNCT00700024Phase 4
• The Effect of IM Testosterone Undecanoate on Biochemical and Anthropometric Characteristics of Metabolic Syndrome in Hypogonadal MenStatus unknownNCT00696748Phase 3
• Effects the Glycemic Index on Metabolic Risk MarkersCompletedNCT00695825Not applicable
• Prevalence of Metabolic Syndrome in Obstructive Sleep Apnea (OSA) and Effect of Treatment With Continuous Positive Airway Pressure (Auto-CPAP) on Metabolic SyndromeCompletedNCT00694616Not applicable
• Regional Observatory on Metabolic Syndrome- LAZIOCompletedNCT00689455
• Exercise Dose-Response on Features of the Metabolic SyndromeCompletedNCT00687128Not applicable
• IT-Based Training in Metabolic SyndromeCompletedNCT00686244Not applicable
• Study to Determine if Olmesartan Medoxomil Has the Potential to Benefit the Cardiovascular System in Terms of Arterial ProtectionCompletedNCT00676845Phase 3
• A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II DiabetesCompletedNCT00675857Phase 2
• Study the Role of Genetic Variation in the Determining Lipid Profile Response to Dietary ChangeCompletedNCT00673023Not applicable
• Diet, Exercise, Metabolism, and Obesity in Older WomenCompletedNCT00664729Not applicable
• Effect of Exercise and Phytoestrogen on Bone, Metabolic Syndrome Criteria and Complaints of the Early MenopauseTerminatedNCT00663104Phase 3
• Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic SyndromeCompletedNCT00659321Phase 3
• Copenhagen Obesity Risk Assessment StudyCompletedNCT00655902Not applicable
• Mechanisms of Metabolic Regulation of Resveratrol on Humans With Metabolic SyndromeWithdrawnNCT00654667Phase 2
• COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome SubjectsCompletedNCT00654485Phase 3
• Metabolic Syndrome and Leptin Level Associated With Fructose Consumption in SpainCompletedNCT00651001
• Effect of Physical Activity on Metabolic Syndrome in Pregnancy & Fetal OutcomeCompletedNCT00647595Phase 3
• Effect of Irvingia Gabonensis (Bush Mango)on Parameters Associated With Metabolic SyndromeCompletedNCT00645775Not applicable
• Mediterranean Diet and the Metabolic SyndromeCompletedNCT00640783Not applicable
• Methionine-Restriction Diet (MRD) in Obese Adults With Metabolic SyndromeCompletedNCT00640757Phase 2
• Safety and Efficacy Study of Pitavastatin in Patient With a Metabolic SyndromeCompletedNCT00640276Phase 4
• The Effect of Allopurinol on Insulin Resistance and Blood PressureCompletedNCT00639756Phase 2
• Diagnosis and Therapy of Vulnerable Atherosclerotic PlaqueCompletedNCT00636766Not applicable
• Antipsychotics and Metabolic SyndromeSuspendedNCT00636753
• Effects of Infliximab on Insulin Sensitivity and Beta Cell Function in Insulin Resistant Human ObesityCompletedNCT00636142Phase 4
• Effects of CPAP on Cardiovascular Risk in Obstructive Sleep Apnea (OSA) and Metabolic SyndromeCompletedNCT00635674Not applicable
• The Study of Metabolic Syndrome in Hemodialysis PatientsStatus unknownNCT00632879
• Pharmacological Regulation of Fat Transport in Metabolic SyndromeCompletedNCT00632840Phase 4
• Essential Fatty Acids During Complementary FeedingCompletedNCT00631046Not applicable
• Metabolic Syndrome Risk Factor in IGT: STOP-NIDDM TrialCompletedNCT00629213Phase 3
• Homburg Cream & Sugar StudyCompletedNCT00628524
• Antipsychotic Medicine and Metabolic SyndromeStatus unknownNCT00627757
• Yoga for the Management of HIV-Metabolic SyndromesCompletedNCT00627380Phase 4
• Gene Expression in Obesity and Insulin ResistanceCompletedNCT00621205Not applicable
• Evaluation of Fructans Supplementation on Parameters of Metabolic SyndromeCompletedNCT00616057Not applicable
• Insulin Resistance StudySuspendedNCT00614757Not applicable
• Yoga for the Treatment of Metabolic SyndromeCompletedNCT00605436Phase 1
• The Effect of Eating Pulses for 8 Weeks on Satiety and Metabolic Syndrome Risk Factors in Overweight IndividualsCompletedNCT00604448Not applicable
• Magnesium and Metabolic SyndromeCompletedNCT00603499Phase 4
• Study of Growth-promoting and Metabolic Effects of Growth Hormone (rhGH)TerminatedNCT00597480Phase 4
• The Role of Leptin Receptors in NASHCompletedNCT00583999
• Protein, Fiber, and Metabolic Syndrome - The PROFIMET StudyCompletedNCT00579657Not applicable
• Effects of Cilostazol on Plasma Adipocytokine and Arterial StiffnessStatus unknownNCT00573950Phase 4
• Dietary Modulation of Gene Expression and Metabolic Pathways in Glucose MetabolismCompletedNCT00573781Phase 2
• Effect on Metabolic Parameters of Abilify in SPRStatus unknownNCT00569764
• Prevalence of the Metabolic Syndrome in SPR Taking AntipsychoticsStatus unknownNCT00569504
• Adipokines as Predictors of the Metabolic Syndrome in ALL SurvivorsStatus unknownNCT00566566
• Effect of Increased Intake of Low Fat Dairy Products on Weight Loss and Insulin ResistanceCompletedNCT00564551Not applicable
• Effects of High-fat and Low-fat Diet on the GutCompletedNCT00561626Not applicable
• Regulation of Inflammatory Parameters by Telmisartan in Hypertensive PatientsCompletedNCT00560430Phase 3
• Effects of Dietary Proteins on Hepatic Lipid MetabolismCompletedNCT00558740
• The Relation Between Periodontal Disease and Metabolic SyndromeStatus unknownNCT00553007Not applicable
• Complications in Hypertension and ObesityStatus unknownNCT00552292
• Surgical Removal of Visceral Fat Tissue (Omentectomy) Associated to Bariatric Surgery: Effects on Insulin SensitivityCompletedNCT00545805Phase 2/3
• MK0916 in Patients With Type 2 Diabetes and Metabolic Syndrome (0916-005)CompletedNCT00543595Phase 2
• Effect of Genistein in Women With Metabolic SyndromeCompletedNCT00541710Phase 2/3
• Study to Investigate the Pathophysiology of Type 2 Diabetes in YouthCompletedNCT00536250
• Physical Inactivity and Insulin Resistance in Skeletal Muscle.WithdrawnNCT00536211Not applicable
• Metabolic Profile and Anthropometric Changes in SchizophreniaCompletedNCT00534183Not applicable
• Do Antidepressants Induce Metabolic Syndromes METADAP StudyCompletedNCT00526383Not applicable
• Body Composition, Bone Mineral Density, Insulin Sensitivity and Echocardiographic Measurements in Klinefelter SyndromeCompletedNCT00523835
• Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin SensitivityCompletedNCT00523562Not applicable
• The Effects of ProAlgaZyme on HDL Cholesterol in Individuals With Metabolic SyndromeStatus unknownNCT00518960Not applicable
• Continuous Positive Airway Pressure in Sleep Apnea Syndrome: Effects on Metabolic Syndrome and Cardiac DamageStatus unknownNCT00517777Phase 4
• Effect of Exercise Training on the Function of the High Density Lipoprotein (HDL)-Cholesterol, Endothelial Function and Endothelial Progenitor Cells in Patients With Metabolic Syndrome(HERMET-Study)CompletedNCT00515476Not applicable
• Dietary Protein and Insulin Sensitivity StudyCompletedNCT00508937Not applicable
• Effects of Chronic Sleep Restriction in Young and Older PeopleStatus unknownNCT00506428Not applicable
• ProAlgaZyme Novel Algae Infusion: Applications in Metabolic SyndromeCompletedNCT00489333Not applicable
• Effect of Testosterone Replacement on Insulin ResistanceCompletedNCT00487734Phase 4
• Cardiovascular Risk Factors in an Ambulatory Urban Patient PopulationCompletedNCT00486993
• Effects of Ezetimibe Add-On to Statin Therapy on Adipokine Production in Obese and Metabolic Syndrome Patients With AtherosclerosisCompletedNCT00485121Not applicable
• Testosterone Therapy in Men With Low Testosterone Levels and Metabolic Syndrome or Early Stages of Type 2 DiabetesStatus unknownNCT00479609Phase 3
• The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole TrialStatus unknownNCT00468533Phase 4
• Effects of FXR Activation on Hepatic Lipid and Glucose MetabolismCompletedNCT00465751Early Phase 1
• Ppar-Gamma EliminAtes Restenosis Longevity Study: PEARLSTerminatedNCT00465296Phase 3
• Effect of 5 Years of GH Replacement on AtherosclerosisCompletedNCT00462475
• Efficacy and Safety of Berberine in the Treatment of Diabetes With DyslipidemiaCompletedNCT00462046Phase 3
• Weight Loss and Cardiovascular Disease (CVD) Prevention Via a Whole Grain Diet in Men and Women With Metabolic SyndromeCompletedNCT00455065Not applicable
• Telmisartan and Renal Perfusion in Patients With Metabolic SyndromeCompletedNCT00452192Phase 3
• Impact of Pitavastatin in Hypercholesterolemic Patients With Metabolic SyndromeCompletedNCT00444717Phase 4
• Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic SyndromeTerminatedNCT00438321Phase 1
• Family-Centered Diabetes Project - Sharing WisdomCompletedNCT00438126Not applicable
• Insulin Sensitivity in Men With the Metabolic SyndromeSuspendedNCT00433173Not applicable
• Metabolic Syndrome and Inflammatory MarkersCompletedNCT00433082Not applicable
• Acute Single Meal Effects of Trout on Cardiovascular Risk Markers and Plasma ProteomeStatus unknownNCT00432952Not applicable
• Changes in Different Fat Compartments and Their Effect on Particular Manifestations of Metabolic Syndrome After Bariatric Procedures.Status unknownNCT00431587
• Effect of Fasting With Two Meals on Insulin Resistance Indices of Metabolic SyndromeCompletedNCT00429390Not applicable
• The Effect of Dietary Fat Modification on Risk Factors Associated With the Metabolic SyndromeCompletedNCT00429195Not applicable
• The Metabolic Effects of Different Weight Loss DietsCompletedNCT00422630Not applicable
• Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and ThrombosisCompletedNCT00422396Not applicable
• Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible diabeTes (ATTEMPT)CompletedNCT00416741
• Study of TNF-Antagonism in Metabolic SyndromeCompletedNCT00409318Not applicable

← Metabolic Syndrome overview